14,517
Total Claims
$2.6M
Drug Cost
1,520
Beneficiaries
$1,722
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+13%
Cost per patient vs peers
$1,722 vs $1,524 avg
-3%
Brand preference vs peers
13.3% vs 13.7% avg
Brand vs Generic
87% generic
Brand: 1,925 claims · $2.3M
Generic: 12,592 claims · $277K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 675 | $904K |
| Rivaroxaban | 319 | $461K |
| Sacubitril/Valsartan | 195 | $288K |
| Evolocumab | 221 | $214K |
| Dapagliflozin Propanediol | 118 | $139K |
| Alirocumab | 84 | $86K |
| Icosapent Ethyl | 74 | $52K |
| Ticagrelor | 46 | $50K |
| Empagliflozin | 23 | $43K |
| Dronedarone Hcl | 19 | $40K |
| Atorvastatin Calcium | 2,612 | $36K |
| Ezetimibe | 578 | $31K |
| Patiromer Calcium Sorbitex | 16 | $22K |
| Potassium Chloride | 457 | $17K |
| Metoprolol Succinate | 809 | $16K |
Prescribing Profile
63
Unique Drugs
$1.8M
Patient Profile
75
Avg Age
43%
Female
1.46
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data